Terms: = Uterine cancer AND PBX1, P40424, 5087
5 results:
1. Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial cancer.
Zheng S; Donnelly ED; Strauss JB
JAMA Netw Open; 2024 Jan; 7(1):e2351906. PubMed ID: 38231514
[TBL] [Abstract] [Full Text] [Related]
2. pbx1-promoted SFRP4 transcription inhibits cell proliferation and epithelial-mesenchymal transition in endometrial carcinoma.
Guo L; Chen H; Chen J; Gao C; Fu X; Zhou S; Wu W; Li T; Lin J; Yang T; Chen Z; Cao L
Tissue Cell; 2023 Jun; 82():102083. PubMed ID: 37054536
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis.
Huang R; Yu L; Zheng C; Liang Q; Suye S; Yang X; Yin H; Ren Z; Shi L; Zhang Z; Chen H; Fu C
Sci Rep; 2020 Sep; 10(1):14975. PubMed ID: 32917946
[TBL] [Abstract] [Full Text] [Related]
4. Histopathology and Clinical Outcomes of 151 Women with Postmenopausal Bleeding Treated with Resectoscopic Surgery.
Vilos GA; AlJasser R; Vilos AG; Oraif A; Abduljabar H; Abu-Rafea B
J Minim Invasive Gynecol; 2020; 27(3):763-773. PubMed ID: 31202823
[TBL] [Abstract] [Full Text] [Related]
5. Endoscann cell sampling for cytological assessment of endometrial pathology.
Hansen PK; Junge J; Roed H; Fischer-Rasmussen W; Højgaard K
Acta Obstet Gynecol Scand; 1986; 65(5):397-9. PubMed ID: 3776481
[TBL] [Abstract] [Full Text] [Related]
